3K3
5-({(1R,1aS,6bR)-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl}oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one
Find entries where: 3K3
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | 5-({(1R,1aS,6bR)-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl}oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one |
Identifiers | 5-[[(1R,1aS,6bR)-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one |
Formula | C25 H17 F3 N4 O3 |
Molecular Weight | 478.423 |
Type | NON-POLYMER |
Isomeric SMILES | c1cc2c(cc1C(F)(F)F)nc([nH]2)[C@H]3[C@H]4[C@@H]3Oc5c4cc(cc5)Oc6ccnc7c6CCC(=O)N7 |
InChI | InChI=1S/C25H17F3N4O3/c26-25(27,28)11-1-4-15-16(9-11)31-24(30-15)21-20-14-10-12(2-5-17(14)35-22(20)21)34-18-7-8-29-23-13(18)3-6-19(33)32-23/h1-2,4-5,7-10,20-22H,3,6H2,(H,30,31)(H,29,32,33)/t20-,21-,22-/m0/s1 |
InChIKey | NGFFVZQXSRKHBM-FKBYEOEOSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 52 |
Chiral Atom Count | 3 |
Bond Count | 58 |
Aromatic Bond Count | 22 |
Drug Info: DrugBank
DrugBank ID | DB14773 |
---|---|
Name | Lifirafenib |
Groups | investigational |
Description | Lifirafenib is under investigation in clinical trial NCT03641586 (The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor). |
Synonyms | Lifirafenib |
Categories | Heterocyclic Compounds, Fused-Ring |
CAS number | 1446090-79-4 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL4209157 |
PubChem | 89670174 |
ChEMBL | CHEMBL4209157 |